JP Morgan Downgrades Phreesia to Neutral, Lowers Price Target to $16

3/31/2026
Impact: -75
Healthcare

JP Morgan analyst Alexei Gogolev has downgraded Phreesia (NYSE: PHR) from Overweight to Neutral. The price target for the stock has been reduced from $24 to $16.

AI summary, not financial advice

Share: